Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Early erythroferrone levels can predict the long-term haemoglobin responses to erythropoiesis-stimulating agents.

  • Authors : Xu P; School of Pharmacy, The Chinese University of Hong Kong, HKSAR, China.; Phase I Clinical Trial Center, Taihe Hospital, Hubei University of Medicine, Shiyan, China.

Subjects: Hemoglobins*/Hemoglobins*/Hemoglobins*/metabolism ; Erythropoietin*/Erythropoietin*/Erythropoietin*/pharmacology ; Erythropoietin*/Erythropoietin*/Erythropoietin*/administration & dosage

  • Source: British journal of pharmacology [Br J Pharmacol] 2024 Aug; Vol. 181 (16), pp. 2833-2850. Date of Electronic Publication: 2024 Apr 23.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Effect of the Phosphate Binder Sevelamer Carbonate on the Bioavailability of Enarodustat, an Oral Erythropoiesis Stimulating Agent.

  • Authors : Pai SM; Clinical Pharmacology, Akros Pharma Inc., Princeton, NJ, USA.; Yamada H

Subjects: Hematinics*; Humans ; Male

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Jan; Vol. 13 (1), pp. 111-116. Date of Electronic Publication: 2023 Nov 17.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Report

Benefits of intravenous iron supplementation in patients with heart failure: mounting evidence and open questions.

  • Authors : Kalogeropoulos AP; Division of Cardiology, Department of Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA.; Lewis GD

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/complications ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Hematinics*/Hematinics*/Hematinics*/therapeutic use

  • Source: European journal of heart failure [Eur J Heart Fail] 2023 Apr; Vol. 25 (4), pp. 538-540. Date of Electronic Publication: 2023 Mar 08.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Population Pharmacodynamic Modeling of Epoetin Alfa in End-Stage Renal Disease Patients Receiving Maintenance Treatment Using Bayesian Approach.

  • Authors : Nguyen LM; Department of Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, New York, USA.; Meaney CJ

Subjects: Anemia/Anemia/Anemia/*drug therapy ; Epoetin Alfa/Epoetin Alfa/Epoetin Alfa/*pharmacology ; Hematinics/Hematinics/Hematinics/*pharmacology

  • Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2020 Oct; Vol. 9 (10), pp. 596-605. Date of Electronic Publication: 2020 Sep 29.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Population Pharmacokinetics and Exposure-Response of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With Myelodysplastic Syndromes.

  • Authors : Chen N; Bristol Myers Squibb, Princeton, New Jersey, USA.; Kassir N

Subjects: Activin Receptors, Type II/Activin Receptors, Type II/Activin Receptors, Type II/*administration & dosage ; Anemia/Anemia/Anemia/*drug therapy ; Hematinics/Hematinics/Hematinics/*administration & dosage

  • Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2020 Jul; Vol. 9 (7), pp. 395-404. Date of Electronic Publication: 2020 Jun 30.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
  • 1-10 ل  209 نتائج ل ""Hematinics""